Literature DB >> 20619344

Skeletal muscle weakness in osteogenesis imperfecta mice.

Bettina A Gentry1, J Andries Ferreira, Amanda J McCambridge, Marybeth Brown, Charlotte L Phillips.   

Abstract

Exercise intolerance, muscle fatigue and weakness are often-reported, little-investigated concerns of patients with osteogenesis imperfecta (OI). OI is a heritable connective tissue disorder hallmarked by bone fragility resulting primarily from dominant mutations in the proα1(I) or proα2(I) collagen genes and the recently discovered recessive mutations in post-translational modifying proteins of type I collagen. In this study we examined the soleus (S), plantaris (P), gastrocnemius (G), tibialis anterior (TA) and quadriceps (Q) muscles of mice expressing mild (+/oim) and moderately severe (oim/oim) OI for evidence of inherent muscle pathology. In particular, muscle weight, fiber cross-sectional area (CSA), fiber type, fiber histomorphology, fibrillar collagen content, absolute, relative and specific peak tetanic force (P(o), P(o)/mg and P(o)/CSA respectively) of individual muscles were evaluated. Oim/oim mouse muscles were generally smaller, contained less fibrillar collagen, had decreased P(o) and an inability to sustain P(o) for the 300-ms testing duration for specific muscles; +/oim mice had a similar but milder skeletal muscle phenotype. +/oim mice had mild weakness of specific muscles but were less affected than their oim/oim counterparts which demonstrated readily apparent skeletal muscle pathology. Therefore muscle weakness in oim mice reflects inherent skeletal muscle pathology.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20619344      PMCID: PMC2952678          DOI: 10.1016/j.matbio.2010.06.006

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  35 in total

1.  Myocardial mechanics and collagen structure in the osteogenesis imperfecta murine (oim).

Authors:  S M Weis; J L Emery; K D Becker; D J McBride; J H Omens; A D McCulloch
Journal:  Circ Res       Date:  2000-10-13       Impact factor: 17.367

2.  Analysis of covariance using the rank transformation.

Authors:  W J Conover; R L Iman
Journal:  Biometrics       Date:  1982-09       Impact factor: 2.571

3.  Use of the Cre/lox recombination system to develop a non-lethal knock-in murine model for osteogenesis imperfecta with an alpha1(I) G349C substitution. Variability in phenotype in BrtlIV mice.

Authors:  A Forlino; F D Porter; E J Lee; H Westphal; J C Marini
Journal:  J Biol Chem       Date:  1999-12-31       Impact factor: 5.157

4.  Osteogenesis imperfecta: cloning of a pro-alpha 2(I) collagen gene with a frameshift mutation.

Authors:  T Pihlajaniemi; L A Dickson; F M Pope; V R Korhonen; A Nicholls; D J Prockop; J C Myers
Journal:  J Biol Chem       Date:  1984-11-10       Impact factor: 5.157

5.  Impaired performance of skeletal muscle in alpha-glucosidase knockout mice.

Authors:  Reinout P Hesselink; Marchel Gorselink; Gert Schaart; Anton J M Wagenmakers; Joep Kamphoven; Arnold J J Reuser; Ger J Van Der Vusse; Maarten R Drost
Journal:  Muscle Nerve       Date:  2002-06       Impact factor: 3.217

Review 6.  Mutations in type I collagen genes resulting in osteogenesis imperfecta in humans.

Authors:  Anna Gajko-Galicka
Journal:  Acta Biochim Pol       Date:  2002       Impact factor: 2.149

7.  Temperament and physical performance in children with osteogenesis imperfecta.

Authors:  Stacy J Suskauer; Holly L Cintas; Joan C Marini; Lynn H Gerber
Journal:  Pediatrics       Date:  2003-02       Impact factor: 7.124

8.  Properties of collagen in OIM mouse tissues.

Authors:  T J Sims; C A Miles; A J Bailey; N P Camacho
Journal:  Connect Tissue Res       Date:  2003       Impact factor: 3.417

9.  The clinical features of homozygous alpha 2(I) collagen deficient osteogenesis imperfecta.

Authors:  A C Nicholls; G Osse; H G Schloon; H G Lenard; S Deak; J C Myers; D J Prockop; W R Weigel; P Fryer; F M Pope
Journal:  J Med Genet       Date:  1984-08       Impact factor: 6.318

10.  Variable bone fragility associated with an Amish COL1A2 variant and a knock-in mouse model.

Authors:  Ethan Daley; Elizabeth A Streeten; John D Sorkin; Natalia Kuznetsova; Sue A Shapses; Stephanie M Carleton; Alan R Shuldiner; Joan C Marini; Charlotte L Phillips; Steven A Goldstein; Sergey Leikin; Daniel J McBride
Journal:  J Bone Miner Res       Date:  2010-02       Impact factor: 6.741

View more
  24 in total

1.  Are Changes in Composition in Response to Treatment of a Mouse Model of Osteogenesis Imperfecta Sex-dependent?

Authors:  Adele L Boskey; Josephine Marino; Lyudmila Spevak; Nancy Pleshko; Stephen Doty; Erin M Carter; Cathleen L Raggio
Journal:  Clin Orthop Relat Res       Date:  2015-08       Impact factor: 4.176

2.  Myostatin deficiency partially rescues the bone phenotype of osteogenesis imperfecta model mice.

Authors:  A K Oestreich; S M Carleton; X Yao; B A Gentry; C E Raw; M Brown; F M Pfeiffer; Y Wang; C L Phillips
Journal:  Osteoporos Int       Date:  2015-07-16       Impact factor: 4.507

3.  Hindlimb Skeletal Muscle Function and Skeletal Quality and Strength in +/G610C Mice With and Without Weight-Bearing Exercise.

Authors:  Youngjae Jeong; Stephanie M Carleton; Bettina A Gentry; Xiaomei Yao; J Andries Ferreira; Daniel J Salamango; MaryAnn Weis; Arin K Oestreich; Ashlee M Williams; Marcus G McCray; David R Eyre; Marybeth Brown; Yong Wang; Charlotte L Phillips
Journal:  J Bone Miner Res       Date:  2015-05-14       Impact factor: 6.741

4.  Decreasing maternal myostatin programs adult offspring bone strength in a mouse model of osteogenesis imperfecta.

Authors:  Arin K Oestreich; William M Kamp; Marcus G McCray; Stephanie M Carleton; Natalia Karasseva; Kristin L Lenz; Youngjae Jeong; Salah A Daghlas; Xiaomei Yao; Yong Wang; Ferris M Pfeiffer; Mark R Ellersieck; Laura C Schulz; Charlotte L Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-07       Impact factor: 11.205

5.  Skeletal Response to Soluble Activin Receptor Type IIB in Mouse Models of Osteogenesis Imperfecta.

Authors:  Youngjae Jeong; Salah A Daghlas; Yixia Xie; Molly A Hulbert; Ferris M Pfeiffer; Mark R Dallas; Catherine L Omosule; R Scott Pearsall; Sarah L Dallas; Charlotte L Phillips
Journal:  J Bone Miner Res       Date:  2018-06-22       Impact factor: 6.741

Review 6.  Osteogenesis imperfecta: an update on clinical features and therapies.

Authors:  Ronit Marom; Brien M Rabenhorst; Roy Morello
Journal:  Eur J Endocrinol       Date:  2020-10       Impact factor: 6.664

7.  Muscle contraction induces osteogenic levels of cortical bone strain despite muscle weakness in a mouse model of Osteogenesis Imperfecta.

Authors:  Alycia G Berman; Jason M Organ; Matthew R Allen; Joseph M Wallace
Journal:  Bone       Date:  2019-12-02       Impact factor: 4.398

8.  Soluble activin receptor type IIB decoy receptor differentially impacts murine osteogenesis imperfecta muscle function.

Authors:  Youngjae Jeong; Salah A Daghlas; Alp S Kahveci; Daniel Salamango; Bettina A Gentry; Marybeth Brown; R Scott Rector; R Scott Pearsall; Charlotte L Phillips
Journal:  Muscle Nerve       Date:  2017-06-15       Impact factor: 3.217

9.  Gender-dependence of bone structure and properties in adult osteogenesis imperfecta murine model.

Authors:  Xiaomei Yao; Stephanie M Carleton; Arin D Kettle; Jennifer Melander; Charlotte L Phillips; Yong Wang
Journal:  Ann Biomed Eng       Date:  2013-03-28       Impact factor: 3.934

Review 10.  Bone and muscle: Interactions beyond mechanical.

Authors:  Marco Brotto; Lynda Bonewald
Journal:  Bone       Date:  2015-11       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.